Oragenics share price logo

Oragenics

AMEX: OGEN

$0.37

-0.00

(-0.05%)

as on

Oragenics Stock Performance

as on October 31, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.37
    $0.39
    downward going graph

    1.07%

    Downside

    4.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.35
    $1.29
    downward going graph

    6.20%

    Downside

    244.92%

    Upside

    downward going graph

Oragenics share price movements today

Previous Close
$0.37
Open
$0.37
Volume
596.5K
Market Cap
$1.7M
Day's Low - High
$0.37 - $0.39
52 Week Low - High
$0.35 - $1.29

Oragenics Historical Returns

1 Month Return
-23.91 %
3 Month Return
-23.66 %
1 Year Return
-69.58 %
3 Year Return
-99.63 %
5 Year Return
-99.97 %

Oragenics Stock Fundamentals & Key Indicators

Check Oragenics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7M

EPS (TTM)

-3.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.11

Industry PE ratio

-2.98

PEG Ratio

-0.00

EBITDA

-7.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-144.23%

Oragenics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oragenics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.7M-99.97%-0.110.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Oragenics Stock including INR - Dollar returns

The Oragenics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oragenics investment value today

Current value as on today

₹32,540

Returns

-₹67,460

(-67.46%)

Returns from Oragenics Stock

-₹69,593 (-69.59%)

Dollar Impact

₹2,134 (+2.13%)

Analyst Recommendation on Oragenics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Oragenics. Average target price of $2

Oragenics Share Price Target

Get share price movements and forecasts by analysts on Oragenics.

What analysts predicted

81.3%UPSIDE

Target Price

$2

Current Price

$0.374

Analyzed by

7 Analysts

Target

$2.00

Oragenics target price $2, a slight upside of 81.3% compared to current price of $0.374. According to 7 analysts rating.

Indian Investors' Interest in Oragenics Stock

Search interest for Oragenics Stock has increased by 158% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:158% versus previous 30 day period

Oragenics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-2
-2
-3
-2
-1
-3
-2
-2
-2
EBITDA
-2
-2
-2
-3
-1
-1
0
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
0
-
3
-
-
-
Income Before Tax
-2
-2
-2
-3
-2
-2
-3
-2
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
0
0
0
Net Income
-2
-2
-2
-3
-2
-2
-3
-2
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oragenics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-22
-
-
-
-
-
Operating Income
-6
-9
-15
-26
-15
-14
-20
-10
-9
EBITDA
-6
-9
-15
-26
-15
-14
-20
-10
762
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
-
771
Income Before Tax
-6
-9
-15
-26
-15
-14
-20
-10
-9
Income Tax Expense
0
0
0
-
-
-
-
-
0
Net Income
-6
-9
-15
-26
-15
-14
-20
-10
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oragenics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-2
-3
-2
-2
-3
-2
-2
-2
Operating Cash Flow
-3
-1
-1
-2
-2
-1
-2
-2
-2
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
4
-
Financing Cash Flow
1
0
3
0
4
0
12
0
0
0
Change in Cash
-1
0
1
-2
2
-1
9
-7
1
-2

Oragenics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-9
-15
-26
-15
-14
-20
-10
-9,842
Operating Cash Flow
-6
-9
-13
-16
-13
-15
-7
-8
-9,246
Investing Cash Flow
-
0
0
-
0
0
0
-
-
Financing Cash Flow
8
23
11
16
23
0
0
5
16,781
Change in Cash
2
14
-1
0
9
-15
-7
-2
7,534

Global Institutional Holdings in Oragenics

Check out the Institutions with significant holdings in Oragenics.

Funds
Holdings
Fidelity Concord Street Trust
0.50%

Oragenics News & Key Events

  • img

    Today's Timeline - 21 October

    Tue, 05:31 PM

    -

    Oragenics regains compliance with NYSE American standards after resolving stockholder equity deficiency and completing a $16.5 million public offering.

Insights on Oragenics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -37.65K → 3.14M (in $), with an average increase of 101.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 789.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 212.7% return, outperforming this stock by 312.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -2.20M → -2.52M (in $), with an average decrease of 14.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, OGEN stock has moved down by -6.1%

About Oragenics

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patents and biological resources related to pre-fusion coronavirus spike proteins. Additionally, Oragenics is collaborating with Precigen, Inc. and ILH Holdings, Inc. on the advancement and market introduction of MU1140 and its associated compounds. Established in 1996, the company, formerly known as Oragen, Inc., maintains its headquarters in Tampa, Florida.
OrganisationOragenics
Headquarters9015 Town Center Parkway, Lakewood Ranch, FL, 34202, US
IndustryBiotechnology
CEOJanet Huffman

Key Management of Oragenics

Name

Title

Dr. James P. Kelly M.A., M.D.

Chief Medical Officer

Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.

Chief Clinical Officer

Ms. Janet Huffman

CEO, President, Secretary & Treasurer

Mr. John Spencer

Chief Financial Officer

FAQs

What is Oragenics share price today?

Oragenics share price today is $0.37 as on at the close of the market. Oragenics share today touched a day high of $0.39 and a low of $0.37.

What is the 52 week high and 52 week low for Oragenics share?

Oragenics share touched a 52 week high of $1.29 on and a 52 week low of $0.35 on . Oragenics stock price today i.e. is closed at $0.37,which is 71.01% down from its 52 week high and 6.61% up from its 52 week low.

What is Oragenics's market capitalisation today?

Oragenics market capitalisation is $0.00T as on .

How to invest in Oragenics Stock (OGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oragenics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Oragenics Stock (OGEN) from India?

Indian investors can start investing in Oragenics (OGEN) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Oragenics stock (as per the Rupee-Dollar exchange rate as on ). Based on Oragenics share’s latest price of $0.37 as on October 31, 2026 at 8:45 am IST, you will get 26.7380 shares of Oragenics. Learn more about fractional shares .

What are the returns that Oragenics has given to Indian investors in the last 5 years?

Oragenics stock has given -99.97% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?